Date published: 2026-5-9

1-800-457-3801

SCBT Portrait Logo
Seach Input

PDE11A Activators

Phosphodiesterase 11A (PDE11A) is an enzyme within the diverse family of phosphodiesterases that plays a crucial role in the regulation of cellular signaling pathways. PDE11A specifically hydrolyzes cyclic nucleotides, cyclic adenosine monophosphate (cAMP), and cyclic guanosine monophosphate (cGMP), which are key second messengers in numerous signaling cascades. By controlling the intracellular levels of these cyclic nucleotides, PDE11A influences a variety of physiological processes, including but not limited to, smooth muscle regulation, neuronal signaling, and endocrine function. The enzyme's activity thereby serves as a critical regulatory point in the fine-tuning of cellular responses to external stimuli and hormonal signals. The presence of PDE11A in various tissues, such as brain, heart, lung, and skeletal muscle, underscores its widespread importance in human physiology, mediating the cross-talk between different signaling molecules and pathways to maintain cellular homeostasis and respond appropriately to changes in the cellular environment.

The activation of PDE11A, referring to the enhancement of its enzymatic activity toward cAMP and cGMP, is intricately regulated by various mechanisms that ensure the precise control of cyclic nucleotide signaling within the cell. While direct activators of PDE11A per se are not widely reported, the enzyme's activity can be influenced by several factors, including phosphorylation, changes in intracellular ion concentrations, and interactions with other proteins. Phosphorylation by kinases can alter the conformation of PDE11A, increasing its catalytic efficiency or changing its substrate specificity. Similarly, binding of specific ions or regulatory proteins could induce conformational changes that enhance its activity. Furthermore, the cellular localization of PDE11A and its access to cAMP and cGMP can be modulated by interacting proteins, affecting the enzyme's activity indirectly by altering its microenvironment. Understanding the activation mechanisms of PDE11A is crucial for comprehending how cells regulate cyclic nucleotide levels and the downstream signaling pathways they control. This knowledge contributes to the broader understanding of cellular signaling networks and their role in physiological and pathological processes, highlighting the complexity of intracellular regulation and the for targeted modulation of PDE activity in research.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$78.00
$153.00
$740.00
$1413.00
$2091.00
73
(3)

Forskolin activates adenylate cyclase, increasing cAMP levels, which can indirectly influence PDE11A activity.

Theophylline

58-55-9sc-202835
sc-202835A
sc-202835B
5 g
25 g
100 g
$20.00
$32.00
$85.00
6
(0)

A non-selective phosphodiesterase inhibitor, Theophylline increases cAMP and cGMP levels, indirectly influencing PDE11A.

Rolipram

61413-54-5sc-3563
sc-3563A
5 mg
50 mg
$77.00
$216.00
18
(1)

An inhibitor of PDE4, Rolipram increases cAMP levels, which may indirectly affect PDE11A activity.

Cilostamide (OPC 3689)

68550-75-4sc-201180
sc-201180A
5 mg
25 mg
$92.00
$357.00
16
(1)

A PDE3 inhibitor, Cilostamide can increase cAMP levels, potentially influencing PDE11A activity.

IBMX

28822-58-4sc-201188
sc-201188B
sc-201188A
200 mg
500 mg
1 g
$260.00
$350.00
$500.00
34
(1)

A non-selective inhibitor of phosphodiesterases, IBMX increases levels of cAMP and cGMP, thereby indirectly affecting PDE11A.

Vardenafil

224785-90-4sc-362054
sc-362054A
sc-362054B
100 mg
1 g
50 g
$526.00
$735.00
$16653.00
7
(1)

Primarily a PDE5 inhibitor, Vardenafil also raises cGMP levels, which can indirectly influence PDE11A activity.

Papaverine

58-74-2sc-279951
sc-279951A
sc-279951B
10 mg
50 mg
100 mg
$153.00
$265.00
$459.00
(0)

A non-selective phosphodiesterase inhibitor, Papaverine increases cAMP and cGMP levels, affecting PDE11A indirectly.

Vinpocetine

42971-09-5sc-201204
sc-201204A
sc-201204B
20 mg
100 mg
15 g
$55.00
$214.00
$2400.00
4
(1)

A PDE1 inhibitor, Vinpocetine increases cAMP and cGMP levels, indirectly influencing PDE11A activity.

Dipyridamole

58-32-2sc-200717
sc-200717A
1 g
5 g
$31.00
$102.00
1
(1)

An inhibitor of phosphodiesterases and adenosine uptake, Dipyridamole increases cAMP and cGMP levels, affecting PDE11A.

Milrinone

78415-72-2sc-201193
sc-201193A
10 mg
50 mg
$165.00
$697.00
7
(0)

A PDE3 inhibitor, Milrinone increases cAMP levels, potentially influencing PDE11A activity.